Skip to main content
Premium Trial:

Request an Annual Quote

Rosetta Molecular Diagnostics Test Menu Expansion

Rosetta Genomics has expanded its molecular diagnostic test menu by launching three new tests: HEME FISH, BRAF Lung, and NRAS Colon:

  • HEME FISH contains a portfolio of disease-specific diagnostic, prognostic and predictive test panels for various hematologic malignancies. It uses multiple fluorescence in situ hybridization tests to detect DNA amplifications or rearrangements in a number of hematologic cancers, such as leukemias, lymphomas, and myelomas.
  • BRAF Lung is a mutation analysis assay for lung cancer, analyzed using CAST PCR technology.
  • NRAS Colon is a mutation analysis assay for colon cancer, also analyzed using CAST PCR technology.

These test expand the company's tumor service offerings through its Lake Forest, CA-based laboratory.

The Scan

Shape of Them All

According to BBC News, researchers have developed a protein structure database that includes much of the human proteome.

For Flu and More

The Wall Street Journal reports that several vaccine developers are working on mRNA-based vaccines for influenza.

To Boost Women

China's Ministry of Science and Technology aims to boost the number of female researchers through a new policy, reports the South China Morning Post.

Science Papers Describe Approach to Predict Chemotherapeutic Response, Role of Transcriptional Noise

In Science this week: neural network to predict chemotherapeutic response in cancer patients, and more.